# Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects

> **NCT04473417** · PHASE1 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Forxiga
- **DRUG:** DA-2811
- **DRUG:** DA-2811
- **DRUG:** DA-2811

## Key facts

- **NCT ID:** NCT04473417
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-04
- **Primary completion:** 2020-08-26
- **Final completion:** 2020-10-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04473417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04473417, "Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04473417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*